Total Payments
$1,596
2024 Payments
$662.51
Companies
12
Transactions
58
Medicare Patients
5,494
Medicare Billing
$674,461
Payment Breakdown by Category
Food & Beverage$1,480 (92.8%)
Education$115.45 (7.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,480 | 55 | 92.8% |
| Education | $115.45 | 3 | 7.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $391.06 | 19 | $0 (2024) |
| GlaxoSmithKline, LLC. | $323.74 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $258.35 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $153.76 | 3 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $147.92 | 1 | $0 (2024) |
| Mylan Specialty L.P. | $134.68 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $74.21 | 4 | $0 (2023) |
| Genentech USA, Inc. | $36.16 | 2 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $28.57 | 2 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $19.24 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $662.51 | 16 | Regeneron Healthcare Solutions, Inc. ($258.35) |
| 2023 | $401.18 | 15 | GlaxoSmithKline, LLC. ($186.29) |
| 2022 | $246.93 | 12 | AstraZeneca Pharmaceuticals LP ($128.51) |
| 2021 | $46.34 | 2 | AstraZeneca Pharmaceuticals LP ($46.34) |
| 2020 | $56.38 | 3 | AstraZeneca Pharmaceuticals LP ($23.96) |
| 2019 | $110.07 | 6 | AstraZeneca Pharmaceuticals LP ($66.60) |
| 2018 | $72.34 | 4 | Genentech USA, Inc. ($24.23) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $147.92 | General |
| Category: CRITICAL CARE | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $86.66 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/20/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/26/2024 | Regeneron Healthcare Solutions, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 04/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Respiratory | ||||||
| 03/26/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/07/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: IMMUNOLOGY | ||||||
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Respiratory | ||||||
| 02/08/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $9.68 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 01/12/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Respiratory | ||||||
| 11/16/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Respiratory | ||||||
| 11/16/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Immunology | ||||||
| 11/16/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.25 | General |
| Category: RESPIRATORY | ||||||
| 11/02/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: DIABETES | ||||||
| 10/19/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.54 | General |
| Category: IMMUNOLOGY | ||||||
| 09/21/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: Respiratory | ||||||
| 06/29/2023 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,169 | 1,701 | $627,482 | $151,456 |
| 2022 | 13 | 1,339 | 1,929 | $711,312 | $176,886 |
| 2021 | 16 | 1,436 | 1,995 | $659,466 | $178,730 |
| 2020 | 23 | 1,550 | 2,107 | $653,867 | $167,390 |
Total Patients
5,494
Total Services
7,732
Medicare Billing
$674,461
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 471 | 741 | $290,472 | $69,247 | 23.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 80 | 214 | $149,586 | $36,188 | 24.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 81 | 163 | $37,443 | $10,243 | 27.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 76 | 77 | $33,418 | $7,846 | 23.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 40 | 83 | $27,427 | $7,838 | 28.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $13,480 | $3,336 | 24.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 106 | 106 | $20,246 | $3,116 | 15.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 69 | 69 | $12,696 | $3,040 | 23.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 68 | 68 | $11,764 | $2,948 | 25.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 20 | $11,020 | $2,482 | 22.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $7,007 | $1,532 | 21.9% |
| 31622 | Diagnostic exam of lung airway using an endoscope | Facility | 2023 | 11 | 13 | $5,486 | $1,353 | 24.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 15 | 15 | $2,125 | $1,126 | 53.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 15 | $2,160 | $472.05 | 21.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 39 | 39 | $1,599 | $310.08 | 19.4% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 28 | 28 | $812.00 | $198.24 | 24.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 19 | 19 | $741.00 | $181.26 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 416 | 670 | $258,472 | $64,867 | 25.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 114 | 286 | $199,914 | $49,942 | 25.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 166 | 325 | $106,600 | $26,925 | 25.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 116 | 118 | $51,212 | $12,358 | 24.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 154 | 156 | $29,646 | $4,935 | 16.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 94 | 94 | $17,296 | $4,517 | 26.1% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 95 | 95 | $16,435 | $4,352 | 26.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $16,490 | $4,076 | 24.7% |
About Dr. Daniel Sousa, MD
Dr. Daniel Sousa, MD is a Pulmonary Disease healthcare provider based in Fall River, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285744698.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Sousa, MD has received a total of $1,596 in payments from pharmaceutical and medical device companies, with $662.51 received in 2024. These payments were reported across 58 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,480).
As a Medicare-enrolled provider, Sousa has provided services to 5,494 Medicare beneficiaries, totaling 7,732 services with total Medicare billing of $674,461. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease, Critical Care Medicine
- Location Fall River, MA
- Active Since 08/30/2006
- Last Updated 01/22/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1285744698
Products in Payments
- NUCALA (Biological) $233.15
- TEZSPIRE (Biological) $170.14
- TERLIVAZ (Drug) $147.92
- DUPIXENT (Biological) $146.43
- YUPELRI (Drug) $134.68
- JARDIANCE (Drug) $124.97
- FASENRA (Biological) $107.35
- TRELEGY ELLIPTA (Drug) $90.59
- FASENRA (Drug) $90.56
- CUVITRU (Biological) $74.21
- XOLAIR (Biological) $28.57
- AIRSUPRA (Drug) $23.01
- Utibron (Drug) $19.24
- GENERAL BRONCHIAL THERMOPLASTY (Device) $14.98
- SPIRIVA RESPIMAT (Drug) $14.90
- STIOLTO RESPIMAT (Drug) $13.89
- Xolair (Biological) $11.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Fall River
Dr. Brendan Carolan, Md, MD
Pulmonary Disease — Payments: $10,587
Pulmonary Disease $10,587
Alejandro Lorenzana, M.d, M.D
Pulmonary Disease — Payments: $8,627
Pulmonary Disease $8,627
Dr. Timur Graham, M.d, M.D
Pulmonary Disease — Payments: $5,469
Pulmonary Disease $5,469
Dr. Lelia Lamp, M.d, M.D
Pulmonary Disease — Payments: $1,059
Pulmonary Disease $1,059
Dr. Nick Mucciardi, Md, MD
Pulmonary Disease — Payments: $973.88
Pulmonary Disease $973.88
Essam Awad, Md, MD
Pulmonary Disease — Payments: $648.52
Pulmonary Disease $648.52